This article is part of a Chronicle. See more from this Chronicle
Jeremy de Douhet, Axel Schulz, Jun 14, 2007
This article was originally published in Competition Policy Insight. It is republished here with permission.
On 14 March 2007 the French Competition Council issued a decision imposing a EUR 10 million fine on GlaxoSmithKline France (GSK France) for predatory pricing. The investigation was the result of a complaint by a generic manufacturer, Flavelab, and resulted in the first ever predat
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.19.30.232
Please verify email or join us to access premium content!